|
|||||
|
|
The Neuroimmune Pharmacology of SARS-CoV-2 |
|
| Authors: | Kumar Santosh Yelamanchili Sowmya Seth Pankaj Bidlack Jean M. Pendyala Gurudutt Maggirwar Sanjay Chang Sulie L. |
| Affiliation: | 1.Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN, USA ;2.Department of Anesthesiology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA ;3.Cellular and Molecular Neuroscience, National Brain Research Center, Panesar, Haryana, India ;4.Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA ;5.Department of Microbiology, Immunology & Tropical Medicine, George Washington University School of Medicine and Health Sciences, Washington D.C., USA ;6.Institute of Neuroimmune Pharmacology and Department of Biological Sciences, Seton Hall University, South Orange, NJ, USA ; |
| Abstract: | This guest commentary introduces “The Neuroimmune Pharmacology of SARS-CoV-2,” a special theme issue for The Journal of Neuroimmune Pharmacology led by the Society on NeuroImmune Pharmacology. The issue builds on the Society’s Virtual Workshop on COVID-19 held April 9, 2021. Graphical abstractTop row from left: Drs. Santosh Kumar, Sowmya Yelamanchili, Pankaj Seth, Jean M. Bidlack; Bottom row from left: Drs. Gurudutt Pendyala, Sanjay Maggirwar, and Sulie L. Chang.  |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |